All News

Dupilumab is Safe and Effective Across Pediatric Populations with Severe Atopic Dermatitis: New Meta-Analysis
March 31, 2025

Dupilumab significantly improved measures of severe AD, including EASI and IGA, as well as pruritis in pediatric populations aged 6 months to 18 years vs placebo.

CagriSema Achieves Significant Weight Loss in Phase 3 Trial: Daily Dose
March 31, 2025

Your daily dose of the clinical news you may have missed.

New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
March 28, 2025

New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.

Women's Heart Health: 5 Studies from ACC.25
March 28, 2025

The risks to women's CV health differ, often significantly, from those faced by men, as demonstrated by 5 abstracts from the American College of Cardiology 2025 annual meeting.

Cleveland Clinic Researchers Develop Risk-Prediction Model for Early-Onset Colorectal Cancer in Young Adults
March 28, 2025

The model identified BMI, tobacco use, and family history of CRC as the strongest predictors for advanced neoplasia in young adults.

Pediatric Fentanyl Poisonings Spiral Up 1,200% Over 8 Years, Study Finds
March 28, 2025

In the pediatric population aged 0 to 19 years, exposure to fentanyl was through intentional use by two-thirds, investigators found.

Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose
March 28, 2025

Your daily dose of the clinical news you may have missed.

April Issue of Patient Care Digital Edition is Now Live
March 27, 2025

The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.

Decline in Smoking Averted Nearly 4 Million Lung Cancer Deaths in the US, Study Estimates
March 27, 2025

The number of lung cancer deaths averted represents more than 51% of the expected reduction in total cancer deaths, researchers reported.

Omnipod 5 System Leads to Significant Glycemic Improvements After Direct Transition from MDI Insulin with CGM
March 27, 2025

Mean reduction in HbA1c was nearly 1% after transition from MDI plus CGM to Omnipod 5 in the first randomized trial to evaluate the shift in mode of insulin delivery.